Evidence map›Paper›PMID 21191015›Full record

ArticleJournal of virology2011

Factors supporting intrathecal humoral responses following viral encephalomyelitis.

Timothy W Phares, Cristina P Marques, Stephen A Stohlman, David R Hinton, Cornelia C Bergmann

Open access · bronzeAbstract read
In one paragraph

Article in Journal of virology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Inflammatory CD11bPathogens (Basel, Switzerland) · 2024
    Article
  8. Review
  9. Review
  10. Further characterization ofFrontiers in immunology · 2023
    Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Review
  18. Article
  19. Clinical utility of a molecular signature in inflammatory demyelinating disease.Neurology(R) neuroimmunology & neuroinflammation · 2019
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Timothy W PharesDepartment of Neurosciences, Lerner Research Institute, Cleveland Clinic, 9500 Euclid Avenue, NC30, Cleveland, OH 44195, USA.
Cristina P Marques
Stephen A Stohlman
David R Hinton
Cornelia C Bergmann
Cleveland Clinic Lerner College of Medicine · USUniversity of Southern California · US

Funding

Immune Regulation of CNS Viral RecrudescenceR01AI047249 · NIAID · UNIVERSITY OF SOUTHERN CALIFORNIA · PI BERGMANN, CORNELIA · 2001 to 2010
$3.1M
Immune Regulation of Viral RecrudescenceR56AI047249 · NIAID · CLEVELAND CLINIC LERNER COM-CWRU · PI BERGMANN, CORNELIA · 2012 to 2012
$393k
NIAID NIH HHS AI 47249NIAID NIH HHS R01 AI047249NIAID NIH HHS R56 AI047249
6 · The paper itself

Abstract

Central nervous system (CNS) infections and autoimmune inflammatory disorders are often associated with retention of antibody-secreting cells (ASC). Although beneficial or detrimental contributions of ASC to CNS diseases remain to be defined, virus-specific ASC are crucial in controlling persistent CNS infection following coronavirus-induced encephalomyelitis. This report characterizes expression kinetics of factors associated with ASC homing, differentiation, and survival in the spinal cord, the prominent site of coronavirus persistence. Infection induced a vast, gamma interferon (IFN-γ)-dependent, prolonged increase in chemokine (C-X-C motif) ligand 9 (CXCL9), CXCL10, and CXCL11 mRNA, supporting a role for chemokine (C-X-C motif) receptor 3 (CXCR3)-mediated ASC recruitment. Similarly, CD4 T cell-secreted interleukin-21, a critical regulator of both peripheral activated B cells and CD8 T cells, was sustained during viral persistence. The ASC survival factors B cell-activating factor of the tumor necrosis factor (TNF) family (BAFF) and a proliferating-inducing ligand (APRIL) were also significantly elevated in the infected CNS, albeit delayed relative to the chemokines. Unlike IFN-γ-dependent BAFF upregulation, APRIL induction was IFN-γ independent. Moreover, both APRIL and BAFF were predominantly localized to astrocytes. Last, the expression kinetics of the APRIL and BAFF receptors coincided with CNS accumulation of ASC. Therefore, the factors associated with ASC migration, differentiation, and survival are all induced during acute viral encephalomyelitis, prior to ASC accumulation in the CNS. Importantly, the CNS expression kinetics implicate rapid establishment, and subsequent maintenance, of an environment capable of supporting differentiation and survival of protective antiviral ASC, recruited as plasmablasts from lymphoid organs.

Indexed as

AnimalsAntibodies, ViralAntigen-Presenting CellsCoronavirusCoronavirus InfectionsCytokinesEncephalomyelitisMiceMice, Inbred C57BLSpinal CordAntibodies, ViralCytokines

Identifiers

PMID21191015
PMCPMC3067923
OpenAlexW2002236587

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.